You are here: Industry Insights > divest

News List

Bayer to divest Animal Health unit for $7.6bn pharmaceutical-technology
August 22, 2019
Bayer has signed a definitive agreement to sell its Animal Health unit to US-based Elanco Animal Health for a total of $7.6bn, in a bid to focus on its core life sciences businesses.
Dr Reddy’s announces closure of the transaction to divest Zembrace SymTouch and Tosymra to Upsher-Smith expresspharma
July 23, 2019
Dr Reddy’s Laboratories announced the closure of the transaction with Upsher-Smith Laboratories after the satisfactory completion of all customary closing conditions including the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvement
BMS to divest Otezla for approval of $74bn merger with Celgene pharmaceutical-technology
June 26, 2019
Bristol-Myers Squibb (BMS) has offered to divest prescription medicine Otezla in order to receive approval for its $74bn merger with Celgene from the US Federal Trade Commission (FTC).
Takeda looking to divest emerging-market assets in wake of Shire acquisition firstwordpharma
January 22, 2019
According to people familiar with the matter, Takeda is mulling a sale of some emerging-market drugs as the company looks to find ways to cut debt after its $62-billion takeover of Shire earlier this month, Bloomberg reported Monday.